Your browser doesn't support javascript.
loading
Suicide and suicide risk.
Turecki, Gustavo; Brent, David A; Gunnell, David; O'Connor, Rory C; Oquendo, Maria A; Pirkis, Jane; Stanley, Barbara H.
Afiliación
  • Turecki G; McGill Group for Suicide Studies, Department of Psychiatry, McGill University, Douglas Mental Health University Institute, Montreal, Quebec, Canada. gustavo.turecki@mcgill.ca.
  • Brent DA; Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA.
  • Gunnell D; National Institute of Health Research Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • O'Connor RC; Department of Population Health Sciences, University of Bristol, Bristol, UK.
  • Oquendo MA; Suicidal Behaviour Research Laboratory, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Pirkis J; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Stanley BH; Centre for Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
Nat Rev Dis Primers ; 5(1): 74, 2019 10 24.
Article en En | MEDLINE | ID: mdl-31649257
ABSTRACT
Although recent years have seen large decreases in the overall global rate of suicide fatalities, this trend is not reflected everywhere. Suicide and suicidal behaviour continue to present key challenges for public policy and health services, with increasing suicide deaths in some countries such as the USA. The development of suicide risk is complex, involving contributions from biological (including genetics), psychological (such as certain personality traits), clinical (such as comorbid psychiatric illness), social and environmental factors. The involvement of multiple risk factors in conveying risk of suicide means that determining an individual's risk of suicide is challenging. Improving risk assessment, for example, by using computer testing and genetic screening, is an area of ongoing research. Prevention is key to reduce the number of suicide deaths and prevention efforts include universal, selective and indicated interventions, although these interventions are often delivered in combination. These interventions, combined with psychological (such as cognitive behavioural therapy, caring contacts and safety planning) and pharmacological treatments (for example, clozapine and ketamine) along with coordinated social and public health initiatives, should continue to improve the management of individuals who are suicidal and decrease suicide-associated morbidity.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Suicidio Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Rev Dis Primers Año: 2019 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Suicidio Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Rev Dis Primers Año: 2019 Tipo del documento: Article País de afiliación: Canadá